Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving transferase
Reexamination Certificate
2002-09-20
2008-08-05
Weber, Jon (Department: 1657)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving transferase
Reexamination Certificate
active
07407772
ABSTRACT:
A method for screening statins in their open acid form to determine the susceptibility of each tested statin to metabolic glucuronidation is provided. Also provided is a method for determining if a non-statin pharmaceutical drug co-administered with a statin that is susceptible to metabolic glucuronidation in its open acid form, will inhibit the glucuronidation of the statin and thereby increase the risk of an adverse drug interaction.
REFERENCES:
patent: 6319678 (2001-11-01), Trubetskoy et al.
patent: WO 02/058732 (2002-08-01), None
Kojima J et al (1999) Identification of metabolites of NK-104, an HMG-CoA reductase inhibitor, in rat, rabbit and dog bile. Biol Pharm Bull, vol. 22, No. 2, pp. 142-150.
Prueksaritanont, et al., Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins; The Journal of Pharmacology and Experimental Therapeutics, vol. 301, No. 3; pp. 1042-1051, 2002.
Physician's Deck Reference, online version, printed Jul. 28, 2004, for ZOCOR, pp. 1, 8, 10, 16, and 17 of 20.
Prueksaritanont, et al., Effects of Fibrates on Metabolism of Statins in Human Hepatocytes; Drug Metabolism and Disposition, vol. 30, No. 11; pp. 1280-1287, 2002.
Jamal, et al., Rhabdomyolysis Associated With Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors; American Heart Journal; vol. 147, No. 6, pp. 956-965, 2004.
Prueksaritanont, et al., Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization; Drug Metabolism and Disposition; vol. 30, No. 5, pp. 505-512, 2002.
Everett, et al, Biotransformation of Pravastatin Sodium in Humans; Drug Metabolism and Diposition; vol. 19, No. 4, pp. 740-748, 1991.
Mercenne, et al, Effects of simvastatin, a lipoprotein-lowering drug, on the hepatic enzymes involved in drug metabolism in the Wistar rat; Xenobiotica, vol. 21, No. 7, pp. 859-864, 1991.
Uchiyama, et al, Metabolic fate of 2,2,-dimethylbutyryl moiety of simvastatin in rats: Identificatin of metabolites by gas chromatography/mass spectrometry; European Journal of Drug Metabolism and Pharmacokinetics, vol. 16, No. 3, pp. 189-196, 1991.
Dain, et al, Biotransformation of Fluvastatin Sodium in Humans; Drug Metabolism and Disposition, vol. 21, No. 4, pp. 567-572, 1993.
Halpin, et al, Biotransformation of Lovastatin; Drug Metabolism and Disposition, vol. 21, No. 6, pp. 1003-1011, 1993.
Boberg, et al, Biotransformation of Cerivastatin in Mice, Rats, and Dogs In Vivo; Drug Metabolism and Disposition, vol. 26, No. 7, pp. 640-652, 1998.
Black, et al, Metabolism and Excretion of Atorvastatin in Rats and Dogs; Drug Metabolism and Disposition, vol. 27, No. 8, pp. 916-923, 1999.
Evans, et al, The Myotoxicity of Statins; Current Opinion in Lipidology, vol. 13, No. 4, pp. 415-420, Aug. 2002.
Davidson, Michael, Combination Therapy for Dyslipidemia: Safety and Regulatory Considerations; The American Journal of Cardiology, vol. 90, No. 10B, pp. 50K-60K, Nov. 20, 2002.
Fujino, et al, Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization; Xenobiotica, vol. 33, No. 1, pp. 27-41, 2003. (published online Jan. 1, 2003).
Daniel Mark R.
Merck & Co. , Inc.
Quagliato Carol S.
Srivastava Kailash
Weber Jon
LandOfFree
Screening and selection methods for statin drug combinations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening and selection methods for statin drug combinations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening and selection methods for statin drug combinations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4012277